Pharmaceutical composition comprising enavogliflozin

• Main Authors: KIM GYOUNGWON, PARK MINHYUNG, KIM GWANYOUNG, YOUN SEUNGBIN, LEE SEOYEO, CHO SANGEUN, HWANG ON, LEE HEEWON, HA SONGYI
• Format: Patent
• Language: English; Korean
• Published: 06.04.2023
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention relates to a pharmaceutical composition comprising enavogliflozin, which is a selective inhibitor of sodium-glucose cotransporter 2. The pharmaceutical composition comprising a compound of chemical formula 1 according to the present invention enables implementation of a formulation having excellent content uniformity, formulation uniformity, elution profile, and the like, despite comprising a low dose of a drug. 본 발명은 나트륨-포도당 공동수송체 2(sodium-glucose cotransporter 2)의 선택적 억제제인 이나보글리플로진 을 포함하는 약학 조성물에 관한 것이다. 본 발명에 따른 화학식 1의 화합물을 포함하는 약학 조성물은 저용량의 약물을 포함함에도 불구하고 함량 균일성, 제제 균일성, 용출 프로파일 등이 모두 우수한 제제를 구현할 수 있게 해 준다.